The effect of CD34+cell and lymphocyte supgroups in the donor aphaeresis product on allogeneic peripheral haematopoietic stem cell transplantation

被引：0
|
作者：
Yeral, M. [1 ]
Ozdogu, H. [1 ]
Boga, C. [1 ]
Kozanoglu, I. [1 ]
Karakus, S. [1 ]
Sozer, O. [1 ]
机构：
[1] Baskent Univ Hosp, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [21] Effect of CD34+cell dose on clinical outcomes after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Pedraza, A.
    Salas, M. Q.
    Rodriguez-Lobato, L. G.
    Charry, P.
    Suarez-Lledo, M.
    Martinez-Cibrian, N.
    Domenech, A.
    Solano, M. T.
    Arcarons, J.
    Llobet, N.
    Cid, J.
    Lozano, M.
    Rosinol, L.
    Gutierrez-Garcia, G.
    Urbano-Ispizua, A.
    Fernandez-Aviles, F.
    Rovira, M.
    Martinez, C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 400 - 400
  • [22] The High CD34+Cell Count in Premobilization Peripheral Blood Predicts an Earlier Start of Leukapheresis and a Sufficient CD34+Cell Yield in Autologous Hematopoietic Stem Cell Transplantation Patients
    不详
    TRANSFUSION, 2014, 54 : 23A - 23A
  • [23] CD34+cell dose, reduced-intensity conditioning and prior chemotherapy:: factors with significant impact on the kinetics of donor chimerism after allogeneic haematopoietic cell transplantation
    Mohr, B
    Koch, R
    Thiede, C
    Kroschinsky, F
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S101 - S101
  • [24] The CD34+cell dose, even in an "acceptable" range, affects outcome of allogeneic blood stem cell transplantation.
    Singhal, S
    Gordon, L
    Meagher, R
    Evens, A
    Tallman, M
    Williams, S
    Winter, J
    Grinblatt, D
    Kaminer, L
    Mehta, J
    BLOOD, 2004, 104 (11) : 326A - 327A
  • [25] The High CD34+Cell Count in Premobilization Peripheral Blood Predicts an Earlier Start of Leukapheresis and a Sufficient CD34+Cell Yield in Autologous Hematopoietic Stem Cell Transplantation Patients
    Sato, T.
    Watanabe-Okochi, N.
    Masamoto, Y.
    Yoshizato, T.
    Ikeda, T.
    Matsuhashi, M.
    Iino, J.
    Mishima, Y.
    Yoshikawa, N.
    Masuda, A.
    Yatomi, Y.
    Tsuno, H. N.
    Okazaki, H.
    TRANSFUSION, 2014, 54 : 23A - 23A
  • [26] High CD34+cell dose is associated with increased early mortality after allogeneic hematopoietic stem cell transplantation
    Neumann, K.
    Lange, S.
    Kragl, B.
    Glass, Ae
    Grosse-Thie, C.
    Wittke, C.
    Freitag, S.
    Henze, L.
    Kleine, H. -D
    Junghanss, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 80 - 80
  • [27] CD34+-selected stem cell boost for poor graft function after allogeneic haematopoietic stem cell transplantation
    Klyuchnikov, E.
    Elcheikh, J.
    Blaise, D.
    Bacher, U.
    Ayuk, F.
    Lioznov, M.
    Alchalby, H.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S338 - S338
  • [28] Effect of hypercholesterolaemia on peripheral blood CD34+cell levels
    Ozkan, M. Comert
    Simsir, I. Yildirim
    Yurekli, B. Sarer
    Basol, G.
    Yavasoglu, I.
    Kabaroglu, C.
    Saygili, F.
    Bolaman, Z.
    Tombuloglu, M.
    Donmez, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S356 - S356
  • [29] Effect of CD34+cell dose on outcome of allogeneic hematopoietic stem cell with myelodysplastic syndrome in children and adolescents
    Osipova, A.
    Afanasyev, B.
    Zubarovskaya, L.
    Semenova, E.
    Bykova, T.
    Razumova, S.
    Borovkova, A.
    Kojokar, P.
    Paina, O.
    Morozova, E.
    Ovetchkina, V.
    Alyanskiy, A.
    Babenko, E.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S476 - S476
  • [30] Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
    Elisa Roldan
    Miguel Angel Perales
    Pere Barba
    Clinical Hematology International, 2019, 1 (3) : 154 - 160
12345